Search

Your search keyword '"Mo Youl Beck"' showing total 14 results

Search Constraints

Start Over You searched for: Author "Mo Youl Beck" Remove constraint Author: "Mo Youl Beck" Topic medicine Remove constraint Topic: medicine
14 results on '"Mo Youl Beck"'

Search Results

1. Phase II Trial of Continuous Regorafenib Dosing in Patients with Gastrointestinal Stromal Tumors After Failure of Imatinib and Sunitinib

2. Systemic Steroid Treatment for Imatinib-Associated Severe Skin Rash in Patients with Gastrointestinal Stromal Tumor: A Phase II Study

3. Severe Imatinib-Associated Skin Rash in Gastrointestinal Stromal Tumor Patients: Management and Clinical Implications

4. Changes in imatinib plasma trough level during long-term treatment of patients with advanced gastrointestinal stromal tumors: correlation between changes in covariates and imatinib exposure

5. Phase II study of paclitaxel in patients with advanced gastrointestinal stromal tumor (GIST) after failure of at least both imatinib and sunitinib

6. Systemic steroid treatment for severe skin rash induced by imatinib in patients with gastrointestinal stromal tumor (GIST): A phase II study

7. Phase II trial of continuous dosing of regorafenib in patients with metastatic or recurrent gastrointestinal stromal tumors (GISTs) after failure of imatinib and sunitinib

8. Efficacy, safety, and pharmacokinetics of imatinib dose escalation to 800 mg/day in patients with advanced gastrointestinal stromal tumors

9. Nilotinib in patients with GIST who failed imatinib and sunitinib: importance of prior surgery on drug bioavailability

10. Cross-sectional study of imatinib plasma trough levels in patients with advanced gastrointestinal stromal tumors: impact of gastrointestinal resection on exposure to imatinib

11. Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor

12. Pharmacokinetics of escalated dose of imatinib in patients with advanced gastrointestinal stromal tumors

13. Changes in imatinib plasma trough level during long-term treatment of patients with advanced gastrointestinal stromal tumors

14. Nilotinib for patients with advanced GIST who failed imatinib and sunitinib: Negative effect of prior major gastrectomy on exposure to nilotinib

Catalog

Books, media, physical & digital resources